No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SPRB Spruce Biosciences
- 0.751
- -0.016-2.06%
Close May 22 16:00 ET
- 0.753
- +0.002+0.23%
Post 18:42 ET
30.91MMarket Cap-670P/E (TTM)
0.769High0.750Low162.49KVolume0.769Open0.767Pre Close123.67KTurnover0.66%Turnover RatioLossP/E (Static)41.15MShares5.95052wk High0.46P/B18.58MFloat Cap0.67152wk Low--Dividend TTM24.73MShs Float35.600Historical High--Div YieldTTM2.45%Amplitude0.671Historical Low0.761Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocri
Hold Rating on Spruce Biosciences Amid Clinical Trial Uncertainties and Rising Competition
Spruce Biosciences Faces Nasdaq Delisting Threat Over Low Stock Prices
Buy Rating Affirmed for Spruce Biosciences Amid Upcoming Trial Data and Strong Financial Position
Express News | HC Wainwright & Co. Reiterates Neutral on Spruce Biosciences
Spruce Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 — HC Wainwright & Co. Reiterates → Neutral 03/14/2024 143.9% RBC Capital $9 → $2 Downgrades Ou
Comments
🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
5
1
$Spruce Biosciences(SPRB.US$ why did it drop from 5?
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long